A percutan nervus tibialis stimuláció (PTNS) a legegyszerűbb, legkevésbé invazív és jól tolerálható neuromodulációs eljárás az alsó húgyutak és a székletürítés működését befolyásoló terápiás elektrofiziológiai technikák között. A PTNS során a medencefenéki izmok és a húgyhólyag afferens idegeinek stimulációja történik a sacralis plexuson keresztül (S2–4) a nervus tibialis posterior felől egyszer használatos vékony tűelektróda és többször használatos stimulátor segítségével. A széles körű klinikai használat ellenére hatásmechanizmusa nem pontosan ismert. Hatásosnak tekinthető túlműködő hólyag szindróma kezelése során, alkalmazása az Európai Urológiai Társaság vizeletincontinentia-irányelvének megfelelően javasolt antimuszkarinterápiára refrakter nőbetegek esetében. Túlműködő hólyagszindrómában kezelési hatékonysága a sacralis ideg neuromudulációjához hasonló. 2003 óta alkalmazzák székletincontinentia terápiájaként, szerepe azonban a megfelelő vizsgálatok hiánya miatt egyelőre kérdéses. A hagyományos kezelési lépések hatástalansága esetén a krónikus kismedencei fájdalom terápiájában szintén szerephez jut a PTNS. Jelentős mellékhatás a PTNS használata során nem került leírásra. Orv Hetil. 2018; 159(43): 1735–1740.
Yamanishi T, Kamai T, Yoshida K. Neuromodulation for the treatment of urinary incontinence. Int J Urol. 2008; 15: 665–672.
Stoller ML. Afferent nerve stimulation for pelvic floor dysfunction. Eur Urol. 1999; 35(Suppl. 2): 16.
Peters KM, Carrico DJ, Perez-Marrero RA, et al. Randomized trial of percutaneous tibial nerve stimulation versus Sham efficacy in the treatment of overactive bladder syndrome: results from the SUmiT trial. J Urol. 2010; 183: 1438–1443.
Finazzi Agrò E, Campagna A, Sciobica F, et al. Posterior tibial nerve stimulation: is the once-a-week protocol the best option? Minerva Urol Nefrol. 2005; 57: 119–123.
Yoong W, Ridout AE, Damodaram M, et al. Neuromodulative treatment with percutaneous tibial nerve stimulation for intractable detrusor instability: outcomes following a shortened 6-week protocol. BJU Int. 2010; 106: 1673–1676.
Cooperberg MR, Stoller ML. Percutaneous neuromodulation. Urol Clin North Am. 2005; 32: 71–78, vii.
Ridout AE, Yoong W. Tibial nerve stimulation for overactive bladder syndrome unresponsive to medical therapy. J Obstet Gynaecol. 2010; 30: 111–114.
Zhou D, Seraphim A, Yoong W. Tibial sensory neuropathy as a rare complication of percutaneous tibial nerve stimulation. Int Urogynecol J. 2015; 26: 301–302.
Tai C, Chen M, Shen B, et al. Irritation induced bladder overactivity is suppressed by tibial nerve stimulation in cats. J Urol. 2011; 186: 326–330.
Jiang CH, Lindstrom S. Prolonged enhancement of the micturition reflex in the cat by repetitive stimulation of bladder afferents. J Physiol. 1999; 517(Pt 2): 599–605.
Tai C, Shen B, Chen M, et al. Prolonged poststimulation inhibition of bladder activity induced by tibial nerve stimulation in cats. Am J Physiol Renal Physiol. 2011; 300: F385–F392.
Danisman A, Kutlu O, Akkaya E, et al. Tibial nerve stimulation diminishes mast cell infiltration in the bladder wall induced by interstitial cystitis urine. Scand J Urol Nephrol. 2007; 41: 98–102.
Chang CJ, Huang ST, Hsu K, et al. Electroacupuncture decreases c-fos expression in the spinal cord induced by noxious stimulation of the rat bladder. J Urol. 1998; 160: 2274–2279.
Finazzi Agrò E, Rocchi C, Pachatz C, et al. Percutaneous tibial nerve stimulation produces effects on brain activity: study on the modifications of the long latency somatosensory evoked potentials. Neurourol Urodyn. 2009; 28: 320–324.
Haylen BT, de Ridder D, Freeman RM, et al. An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction. Neurourol Urodyn. 2010; 29: 4–20.
Wang Y, Xu K, Hu H, et al. Prevalence, risk factors, and impact on health related quality of life of overactive bladder in China. Neurourol Urodyn. 2011; 30: 1448–1455.
Irwin DE, Milsom I, Hunskaar S, et al. Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC study. Eur Urol. 2006; 50: 1306–1314; discussion 1314–1315.
Stewart WF, Van Rooyen JB, Cundiff GW, et al. Prevalence and burden of overactive bladder in the United States. World J Urol. 2003; 20: 327–336.
Ganz ML, Smalarz AM, Krupski TL, et al. Economic costs of overactive bladder in the United States. Urology 2010; 75: 526–532.
Chapple C, Khullar V, Gabriel Z, et al. The effects of antimuscarinic treatments in overactive bladder: a systematic review and meta-analysis. Eur Urol. 2005; 48: 5–26.
Majoros A, Bajory Z, Pytel A, et al. Ministry of Human Capacities. Guideline on non-neurogenic adult urinary incontinence. [Az Emberi Erőforrások Minisztériuma szakmai irányelve a felnőttkorban előforduló, nem neurogén eredetű vizeletinkontinenciáról.] Egészségügyi Közl. 2016; LXV: 1180–1200. [Hungarian]
Abrams P, Andersson KE, Birder L, et al. Fourth International Consultation on Incontinence Recommendations of the International Scientific Committee: Evaluation and treatment of urinary incontinence, pelvic organ prolapse, and fecal incontinence. Neurourol Urodyn. 2010; 29: 213–240.
Kurdoğlu Z, Carr D, Harmouche J, et al. Short-term results of the efficacy of percutaneous tibial nerve stimulation on urinary symptoms and its financial cost. J Turk Ger Gynecol Assoc. 2018; 19: 7–10.
Nambiar AK, Bosch R, Cruz F, et al. EAU guidelines on assessment and nonsurgical management of urinary incontinence. Eur Urol. 2018; 73: 596–609.
Moossdorff-Steinhauser HF, Berghmans B. Effects of percutaneous tibial nerve stimulation on adult patients with overactive bladder syndrome: a systematic review. Neurourol Urodyn. 2013; 32: 206–214.
Peters KM, Macdiarmid SA, Wooldridge LS, et al. Randomized trial of percutaneous tibial nerve stimulation versus extended-release tolterodine: results from the overactive bladder innovative therapy trial. J Urol. 2009; 182: 1055–1061.
Vecchioli-Scaldazza C, Morosetti C. Effectiveness and durability of solifenacin versus percutaneous tibial nerve stimulation versus their combination for the treatment of women with overactive bladder syndrome: a randomized controlled study with a follow-up of ten months. Int Braz J Urol. 2018; 44: 102–108.
Klingler HC, Pycha A, Schmidbauer J, et al. Use of peripheral neuromodulation of the S3 region for treatment of detrusor overactivity: a urodynamic-based study. Urology 2000; 56: 766–771.
Vandoninck V, van Balken MR, Finazzi Agrò E, et al. Percutaneous tibial nerve stimulation in the treatment of overactive bladder: urodynamic data. Neurourol Urodyn. 2003; 22: 227–232.
van der Pal F, van Balken MR, Heesakkers JP, et al. Percutaneous tibial nerve stimulation in the treatment of refractory overactive bladder syndrome: is maintenance treatment necessary? BJU Int. 2006; 97: 547–550.
Tutolo M, Ammirati E, Heesakkers J, et al. Efficacy and safety of sacral and percutaneous tibial neuromodulation in non-neurogenic lower urinary tract dysfunction and chronic pelvic pain: a systematic review of the literature. Eur Urol. 2018; 73: 406–418.
Perry S, Shaw C, McGrother C, et al. Prevalence of faecal incontinence in adults aged 40 years or more living in the community. Gut 2002; 50: 480–484.
Nelson R, Norton N, Cautley E, et al. Community-based prevalence of anal incontinence. JAMA 1995; 274: 559–561.
Ho YH, Muller R, Veitch C, et al. Faecal incontinence: an unrecognised epidemic in rural North Queensland? Results of a hospital-based outpatient study. Aust J Rural Health 2005; 13: 28–34.
Goode PS, Burgio KL, Halli AD, et al. Prevalence and correlates of fecal incontinence in community-dwelling older adults. J Am Geriatr Soc. 2005; 53: 629–635.
Maeda Y, Laurberg S, Norton C. Perianal injectable bulking agents as treatment for faecal incontinence in adults. Cochrane Database Syst Rev. 2013; 2: CD007959.
Kim DW, Yoon HM, Park JS, et al. Radiofrequency energy delivery to the anal canal: is it a promising new approach to the treatment of fecal incontinence? Am J Surg. 2009; 197: 14–18.
Ruiz Carmona MD, Alos Company R, Roig Vila JV, et al. Long-term results of artificial bowel sphincter for the treatment of severe faecal incontinence. Are they what we hoped for? Colorectal Dis. 2009; 11: 831–837.
Ratto C, Parello A, Donisi L, et al. Novel bulking agent for faecal incontinence. Br J Surg. 2011; 98: 1644–1652.
Shafik A, Ahmed I, El-Sibai O, et al. Percutaneous peripheral neuromodulation in the treatment of fecal incontinence. Eur Surg Res. 2003; 35: 103–107.
Matzel KE. Sacral nerve stimulation for faecal incontinence: its role in the treatment algorithm. Colorectal Dis. 2011; 13(Suppl 2): 10–14.
Gourcerol G, Vitton V, Leroi AM, et al. How sacral nerve stimulation works in patients with faecal incontinence. Colorectal Dis. 2011; 13: e203–e211.
Giani I, Novelli E, Martina S, et al. The effect of sacral nerve modulation on cerebral evoked potential latency in fecal incontinence and constipation. Ann Surg. 2011; 254: 90–96.
Griffin KM, Pickering M, O’Herlihy C, et al. Sacral nerve stimulation increases activation of the primary somatosensory cortex by anal canal stimulation in an experimental model. Br J Surg. 2011; 98: 1160–1169.
Carrington EV, Knowles CH. The influence of sacral nerve stimulation on anorectal dysfunction. Colorectal Dis. 2011; 1(Suppl 2): 5–9.
Govaert B, Pares D, Delgado-Aros S, et al. A prospective multicentre study to investigate percutaneous tibial nerve stimulation for the treatment of faecal incontinence. Colorectal Dis. 2010; 12: 1236–1241.
Mentes BB, Yüksel O, Aydin A, et al. Posterior tibial nerve stimulation for faecal incontinence after partial spinal injury: preliminary report. Tech Coloproctol. 2007; 11: 115–119.
Horrocks EJ, Thin N, Thaha MA, et al. Systematic review of tibial nerve stimulation to treat faecal incontinence. Br J Surg. 2014; 101: 457–468.
ACOG Practice Bulletin No. 51. Chronic pelvic pain. Obstet Gynecol. 2004; 103: 589–605.
Jamieson DJ, Steege JF. The prevalence of dysmenorrhea, dyspareunia, pelvic pain, and irritable bowel syndrome in primary care practices. Obstet Gynecol. 1996; 87: 55–58.
Walter M, Sammer U, Kessler TM. Chronic pelvic pain syndrome: neurostimulation, neuromodulation and acupuncture. Urologe A 2012; 51: 1683–1691.
van Balken MR, Vandoninck V, Messelink BJ, et al. Percutaneous tibial nerve stimulation as neuromodulative treatment of chronic pelvic pain. Eur Urol. 2003; 43: 158–163; discussion 163.
Gokyildiz S, Kizilkaya Beji N, Yalcin O, et al. Effects of percutaneous tibial nerve stimulation therapy on chronic pelvic pain. Gynecol Obstet Invest. 2012; 73: 99–105.
Istek A, Gungor Ugurlucan F, Yasa C, et al. Randomized trial of long-term effects of percutaneous tibial nerve stimulation on chronic pelvic pain. Arch Gynecol Obstet. 2014; 290: 291–298.
Bemelmans BL, Mundy AR, Craggs MD. Neuromodulation by implant for treating lower urinary tract symptoms and dysfunction. Eur Urol. 1999; 36: 81–91.